(Total Views: 449)
Posted On: 01/28/2025 12:40:04 AM
Post# of 149690
Devil's in the details, isn't it...thank you *once again* for taking that extra step and looking at Akero's full report.
AND, why would they allow people taking the GLP-1 receptor agonists to take part? Is it that it's difficult to find enough subjects in a timely manner for a fibrosis study who *don't* have to take it?
AND, why would they allow people taking the GLP-1 receptor agonists to take part? Is it that it's difficult to find enough subjects in a timely manner for a fibrosis study who *don't* have to take it?
(2)
(0)Scroll down for more posts ▼
